Intervention Review

Anthelmintics for people with neurocysticercosis

  1. Katharine Abba1,*,
  2. Sridharan Ramaratnam2,
  3. Lakshmi Narasimhan Ranganathan3

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 17 MAR 2010

Assessed as up-to-date: 18 OCT 2009

DOI: 10.1002/14651858.CD000215.pub4


How to Cite

Abba K, Ramaratnam S, Ranganathan LN. Anthelmintics for people with neurocysticercosis. Cochrane Database of Systematic Reviews 2010, Issue 3. Art. No.: CD000215. DOI: 10.1002/14651858.CD000215.pub4.

Author Information

  1. 1

    Liverpool School of Tropical Medicine, International Health Group, Liverpool, Merseyside, UK

  2. 2

    Apollo Hospitals, Department of Neurology, Chennai, Tamil Nadu, India

  3. 3

    Kilpauk Medical College, Department of Neurology, Chennai, Tamil Nadu, India

*Katharine Abba, International Health Group, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, Merseyside, L3 5QA, UK. K.abba@liverpool.ac.uk.

Publication History

  1. Publication Status: Edited (conclusions changed)
  2. Published Online: 17 MAR 2010

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.